Long-term dietary fructose causes gender-different metabolic and vascular dysfunction in rats: Modulatory effects of resveratrol

Cellular Physiology and Biochemistry

Volumn 37, Issue 4, 2015, Pages 1407-1420

  Pektaş, Mehmet Bilgehan ^a,b   Sadi, Gökhan ^b   Akar, Fatma ^c  

^a AFYON KOCATEPE UNIVERSITY   (Turkey)

^b KARAMANOGLU MEHMETBEY UNIVERSITY   (Turkey)

^c GAZI UNIVERSITY   (Turkey)

Author keywords

ENOS; Fructose; Gender; INOS; Insulin; Metabolic and vascular function; Resveratrol; SIRT1

Indexed keywords

ACETYLCHOLINE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FRUCTOSE; INSULIN; INSULIN RECEPTOR SUBSTRATE 1; INSULIN RECEPTOR SUBSTRATE 2; PHENYLEPHRINE; RESVERATROL; SIRTUIN 1; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN; ANTIOXIDANT; INDUCIBLE NITRIC OXIDE SYNTHASE; INSULIN RECEPTOR SUBSTRATE; IRS2 PROTEIN, RAT; STILBENE DERIVATIVE;

ANIMAL EXPERIMENT; AORTA; ARTICLE; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; DIETARY INTAKE; FEMALE; GENE EXPRESSION; INSULIN BLOOD LEVEL; LONG TERM EXPOSURE; MALE; MEASUREMENT; METABOLIC PARAMETERS; NONHUMAN; OMENTUM; PRIORITY JOURNAL; PROTEIN ANALYSIS; RAT; SEX DIFFERENCE; TRIACYLGLYCEROL BLOOD LEVEL; VASODILATATION; WEIGHT GAIN; ANIMAL; BLOOD; BODY WEIGHT; DIET; DRUG EFFECTS; GENETICS; METABOLISM; REAL TIME POLYMERASE CHAIN REACTION; WISTAR RAT;

ACETYLCHOLINE; ANIMALS; ANTIOXIDANTS; AORTA; BODY WEIGHT; DIET; FEMALE; FRUCTOSE; INSULIN; INSULIN RECEPTOR SUBSTRATE PROTEINS; LIPOPROTEINS, VLDL; MALE; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; PHENYLEPHRINE; RATS; RATS, WISTAR; REAL-TIME POLYMERASE CHAIN REACTION; SEX FACTORS; SIRTUIN 1; STILBENES; TRIGLYCERIDES;

EID: 84945151750     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000430405     Document Type: Article

References (34)

1. Horton TJ, Gayles EC, Prach PA, Koppenhafer TA, Pagliassotti MJ. Female rats do not develop sucrose-induced insulin resistance. Am J Physiol 1997;272:R1571-1576.
2. Gomez-Pérez Y, Amengual-Cladera E, Catalá-Niell A, Thomás-Moyá E, Gianotti M, Proenza AM, Llado I. Gender dimorphism in high-fat-diet-induced insulin resistance in skeletal muscle of aged rats. Cell Physiol Biochem 2008;22:539-548.
3. Stubbins RE, Holcomb VB, Hong J, Núñez NP. Estrogen modulates abdominal adiposity and protects female mice from obesity and impaired glucose tolerance. Eur J Nutr 2012;51:861-870.
4. Coatmellec-Daglioni G. Sexual Dimorphism in Cafeteria Diet-Induced Hypertension Is Associated with Gender-Related Difference in Renal Leptin Receptor Down-Regulation. J Pharmacol Exp Ther 2003;305:362-367.
5. Clark C, Smith W, Lochner A, du Toit EF. The effects of gender and obesity on myocardial tolerance to ischemia. Physiol Res 2011;60:291-301.
6. Barron AM, Rosario ER, Elteriefi R, Pike CJ. Sex-specific effects of high fat diet on indices of metabolic syndrome in 3xTg-AD mice: implications for Alzheimer's disease. PLoS One 2013;8:e78554.
7. Galipeau D, Verma S, McNeill JH. Female rats are protected against fructose-induced changes in metabolism and blood pressure. Am J Physiol Heart Circ Physiol 2002;283:2478-2484.
8. Bantle JP, Raatz SK, Thomas W, Georgopoulos A. Effects of dietary fructose on plasma lipids in healthy subjects. Am J Clin Nutr 2000;72:1128-1134.
9. Tran LT, Yuen VG, McNeill JH. The fructose-fed rat: a review on the mechanisms of fructose-induced insulin resistance and hypertension. Mol Cell Biochem 2009;332:145-159.
10. Akar F, Uludag O, Aydin A, Aytekin YA, Elbeg S, Tuzcu M, Sahin K. High-fructose corn syrup causes vascular dysfunction associated with metabolic disturbance in rats: protective effect of resveratrol. Food Chem Toxicol 2012;50:2135-2141.
11. Babacanoglu C, Yildirim N, Sadi G, Pektas MB, Akar F. Resveratrol prevents high-fructose corn syrup-induced vascular insulin resistance and dysfunction in rats. Food Chem Toxicol 2013;60:160-167.
12. Soylemez S, Gurdal H, Sepici A, Akar F. The effect of long-Derm resveratrol treatment on relaxation to estrogen in aortae from male and female rats: Role of nitric oxide and superoxide. Vascul Pharmacol 2008;49:97-105.
13. Sadi G, Ergin V, Yilmaz G, Pektas MB, Yildirim OG, Menevse A, Akar F. High-fructose corn syrup-induced hepatic dysfunction in rats: improving effect of resveratrol. Eur J Nutr 2015;54:895-904.
14. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265-275.
15. Vos MB, Kimmons JE, Gillespie C, Welsh J, Blanck HM. Dietary fructose consumption among US children and adults: the Third National Health and Nutrition Examination Survey. Medscape J Med 2008;10:160.
16. Ventura EE, Davis JN, Goran MI. Sugar content of popular sweetened beverages based on objective laboratory analysis: focus on fructose content. Obesity (Silver Spring) 2011;19:868-874.
17. Nishikawa S, Yasoshima A, Doi K, Nakayama H, Uetsuka K. Involvement of sex, strain and age factors in high fat diet-induced obesity in C57BL/6J and BALB/cA mice. Exp Anim 2007;56:263-272.
18. Muniyappa R, Sowers JR. Role of insulin resistance in endothelial dysfunction. Rev Endocr Metab Disord 2013;14:5-12.
19. Sadi G, Pektas MB, Koca HB, Tosun M, Koca T. Resveratrol improves hepatic insulin signaling and reduces the inflammatory response in streptozotocin-induced diabetes. Gene 2015;570:213-220.
20. Sun C, Zhang F, Ge X, Yan T, Chen X, Shi X, Zhai Q. SIRT1 improves insulin sensitivity under insulin-resistant conditions by repressing PTP1B. Cell Metab 2007;6:307-319.
21. Zhao CX, Xu X, Cui Y, Wang P, Wei X, Yang S, Edin ML, Zeldin DC, Wang DW. Increased endothelial nitric-oxide synthase expression reduces hypertension and hyperinsulinemia in fructose-Dreated rats. J Pharmacol Exp Ther 2009;328:610-620.
22. Xu X, Zhao CX, Wang L, Tu L, Fang X, Zheng C, Edin ML, Zeldin DC, Wang DW. Increased CYP2J3 expression reduces insulin resistance in fructose-Dreated rats and db/db mice. Diabetes 2010;59:997-1005.
23. Kubota T, Kubota N, Moroi M, Terauchi Y, Kobayashi T, Kamata K, Suzuki R, Tobe K, Namiki A, Aizawa S, Nagai R, Kadowaki T, Yamaguchi T. Lack of insulin receptor substrate-2 causes progressive neointima formation in response to vessel injury. Circulation 2003;107:3073-3080.
24. Nagareddy PR, Xia Z, McNeill JH, MacLeod KM. Increased expression of iNOS is associated with endothelial dysfunction and impaired pressor responsiveness in streptozotocin-induced diabetes. Am J Physiol Heart Circ Physiol 2005;289:2144-2152.
25. Koh KK, Han SH, Quon MJ. Inflammatory markers and the metabolic syndrome: insights from therapeutic interventions. J Am Coll Cardiol 2005;46:1978-1985.
26. Kim F, Pham M, Maloney E, Rizzo NO, Morton GJ, Wisse BE, Kirk EA, Chait A, Schwartz MW. Vascular inflammation, insulin resistance, and reduced nitric oxide production precede the onset of peripheral insulin resistance. Arterioscler Thromb Vasc Biol 2008;28:1982-1988.
27. Pearson KJ, Baur JA, Lewis KN, Peshkin L, Price NL, Labinskyy N, Swindell WR, Kamara D, Minor RK, Perez E, Jamieson HA, Zhang Y, Dunn SR, Sharma K, Pleshko N, Woollett LA, Csiszar A, Ikeno Y, Le Couteur D, Elliott PJ, Becker KG, Navas P, Ingram DK, Wolf NS, Ungvari Z, Sinclair DA, de Cabo R. Resveratrol delays age-related deterioration and mimics transcriptional aspects of dietary restriction without extending life span. Cell Metab 2008;8:157-168.
28. Zhang J, Chen J, Yang J, Xu CW, Pu P, Ding JW J H. Resveratrol attenuates oxidative stress induced by balloon , iang injury in the rat carotid artery through actions on the ERK1/2 and NF-kappa B pathway. Cell Physiol Biochem 2013;31:230-241.
29. Lagouge M, Argmann C, Gerhart-Hines Z, Meziane H, Lerin C, Daussin F, Messadeq N, Milne J, Lambert P, Elliott P, Geny B, Laakso M, Puigserver P, Auwerx J. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell 2006;127:1109-1122.
30. Yao Q-P, Qi Y-X, Zhang P, Cheng B-B, Yan Z-Q, Jiang Z-L. SIRT1 and Connexin40 Mediate the normal shear stress-induced inhibition of the proliferation of endothelial cells co-cultured with vascular smooth muscle cells. Cell Physiol Biochem 2013;31:389-399.
31. Liu X, Shao K, Sun T. SIRT1 regulates the human alveolar epithelial A549 cell apoptosis induced by Pseudomonas aeruginosa lipopolysaccharide. Cell Physiol Biochem 2013;31:92-101.
32. Fröjdö S, Cozzone D, Vidal H, Pirola L. Resveratrol is a class IA phosphoinositide 3-kinase inhibitor. Biochem J 2007;406:511-518.
33. Fröjdö S, Durand C, Molin L, Carey AL, El-Osta A, Kingwell BA, Febbraio MA, Solari F, Vidal H, Pirola L. Phosphoinositide 3-kinase as a novel functional target for the regulation of the insulin signaling pathway by SIRT1. Mol Cell Endocrinol 2011;335:166-176.
34. Gonzalez-Rodriguez A, Mas Gutierrez JA, Sanz-Gonzalez S, Ros M, Burks DJ, Valverde AM. Inhibition of PTP1B restores IRS1-mediated hepatic insulin signaling in IRS2-deficient mice. Diabetes 2010;59:588-599.